| 股票代码 | 603456 | 当期评分 | ||||
| 股票名称 | 九洲药业 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.3286 | 0.6878 | 0.458 | 0.458 | 0.458 | ✘ |
| 销售净利润率(%) | 8.3729 | 11.7494 | 13.6926 | 13.6926 | 13.6926 | ✘ |
| 销售毛利率(%) | 32.1184 | 33.7609 | 35.9245 | 35.9245 | 35.9245 | ✔ |
| 净资产收益率(%) | 5.67 | 8.33 | 8.15 | 8.15 | 8.15 | ✘ |
| 营业增长率(%) | 8.4303 | 8.3014 | 28.5342 | 28.5342 | 28.5342 | ✔ |
| 净利润增长率(%) | 6.2233 | 51.9764 | 77.0639 | 77.0639 | 77.0639 | ✔ |
| 每股收益(%) | 0.2 | 0.3 | 0.16 | 0.04 | 0.3 | ✔ |
| 现金流量比率(%) | 57.7371 | 46.4893 | 2.7058 | 5.446 | 26.6702 | ✔ |
| 三项费用比重(%) | 13.8976 | 15.1594 | 20.9282 | 24.7042 | 17.9543 | ✔ |
| 每股净资产(¥) | 3.4416 | 3.5432 | 3.5191 | 3.5844 | 3.6477 | ✔ |
| 流动比率(%) | 3.2829 | 1.6932 | 1.4667 | 1.5916 | 1.6097 | ✔ |
| 速动比率(%) | 2.1164 | 0.9987 | 0.8375 | 0.9744 | 0.8458 | ✘ |
| 现金比率(%) | 60.2074 | 47.4113 | 43.6613 | 63.3523 | 63.3523 | ✔ |
| 总资产利润率(%) | 4.8367 | 5.9425 | 2.6549 | 0.6682 | 5.0146 | ✔ |
| 主营利润比重% | 310.5564 | 237.3112 | 256.079 | 340.6138 | 220.6437 | ✔ |
| 应收账款(万元) | 55,110.02 | 51,748.67 | 55,531.17 | 38,718.43 | 39,362.55 | ✘ |
| 应收票据(万元) | 4,929.64 | -- | -- | -- | -- | ✘ |
| 预付款项(万元) | 2,370.95 | 1,716.02 | 3,612.53 | 4,937.65 | 6,319.92 | ✔ |
| 存货(万元) | 53,496.22 | 82,788.63 | 102,960.86 | 91,685.14 | 105,635.33 | ✔ |
| 在建工程(万元) | 13,623.82 | 27,378.10 | 30,942.41 | 30,799.80 | 36,890.98 | ✔ |
| 应付款项(万元) | 19,474.14 | 27,281.98 | 30,944.04 | 32,401.55 | 43,239.10 | ✘ |
| 长期借款(万元) | -- | 49,069.90 | 47,039.66 | 49,122.33 | 41,052.94 | ✔ |
| 未分配利润(万元) | 89,174.71 | 92,147.44 | 89,026.02 | 95,392.47 | 100,018.21 | ✘ |
| 商誉(万元) | -- | 7,507.30 | 7,507.30 | 7,507.30 | 7,507.30 | ✔ |
| 流动资产(万元) | 179,937.55 | 265,194.02 | 266,297.00 | 263,106.81 | 263,790.96 | ✔ |
| 流动负债(万元) | 45,859.99 | 119,202.14 | 163,655.17 | 148,546.65 | 138,290.67 | ✔ |
九洲药业603456评分结果 | 69.70分 | 买入/增持 | ||||